In a 2018 survey of 253 women in N'Djamena, 15.8% carried a high-risk type of human papillomavirus, the virus that causes cervical cancer, and about two thirds of the types found are covered by the nine-valent HPV vaccine.
Published as "High prevalence of cervical high-risk human papillomavirus infection mostly covered by Gardasil-9 prophylactic vaccine in adult women living in N'Djamena, Chad". In 2018 the authors surveyed women aged 25 to 65 from five of the city's ten districts, recruited by peer educators through church communities and women's associations and seen at a women's sexual health clinic, La Renaissance Plus. HPV DNA in endocervical swabs was genotyped.
The authors argue that the high share of vaccine-preventable types is the rationale for introducing HPV vaccination for young adolescent girls in Chad, which WHO's data still record as not introduced.
Shares Ministry of Public Health and Prevention, Chad, Cervical cancer.
Shares Ministry of Public Health and Prevention, Chad, Cervical cancer.
Shares Ministry of Public Health and Prevention, Chad, Cervical cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/